MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Dynavax Technologies Corporation Depreciation & Amortization 2011-2026 | DVAX
Annual Depreciation & Amortization Dynavax Technologies Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.63 M | 4.34 M | 3.81 M | 4.3 M | 4.27 M | 8.94 M | 3.62 M | 3.24 M | 2.26 M | 1.36 M | 1.4 M | 1.33 M | 1.21 M | 1.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.94 M | 1.21 M | 3.29 M |
Quarterly Depreciation & Amortization Dynavax Technologies Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1.17 M | - | - | - | 1.12 M | - | - | - | 1.01 M | - | 2.98 M | - | 985 K | - | 3.28 M | - | 1.11 M | - | 3.17 M | 2.06 M | 1.01 M | - | 7.84 M | 3.2 M | 1.7 M | - | 2.51 M | 1.66 M | 823 K | - | 2.46 M | 1.67 M | 789 K | - | 1.57 M | 946 K | 402 K | - | 958 K | 634 K | 335 K | - | 1.02 M | 680 K | 339 K | - | 986 K | 646 K | 319 K | - | 898 K | 592 K | 292 K | - | 1.01 M | 704 K | 360 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.84 M | 292 K | 1.44 M |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AgeX Therapeutics
AGE
|
131 K | - | -10.17 % | $ 12.2 K |  USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Aclaris Therapeutics
ACRS
|
807 K | $ 2.92 | -3.16 % | $ 226 M | USA |
 |
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
24.9 M | $ 11.32 | 0.27 % | $ 732 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
 |
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | USA |
 |
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.96 | -1.51 % | $ 500 M |  Britain |
 |
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
14 K | $ 0.19 | -3.85 % | $ 413 M |  Israel |
 |
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | USA |
 |
BioVie
BIVI
|
229 K | $ 1.13 | -2.59 % | $ 1.67 M | USA |
 |
Athersys
ATHX
|
1.43 M | - | 3.77 % | $ 22.4 M | USA |
 |
Catalyst Biosciences
CBIO
|
1.07 M | $ 11.52 | -2.87 % | $ 758 M | USA |
 |
Certara
CERT
|
1.99 M | $ 8.75 | -0.68 % | $ 1.4 B | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
11 K | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | USA |
 |
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
9.45 M | - | -15.15 % | $ 60.3 M | Britain |
 |
bluebird bio
BLUE
|
28 M | - | - | $ 546 M | USA |
 |
Cellectar Biosciences
CLRB
|
192 K | $ 3.2 | 8.47 % | $ 39.1 M | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |
 |
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
28.2 M | $ 26.25 | -1.98 % | $ 1.27 B | USA |
 |
BeiGene, Ltd.
BGNE
|
172 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Anika Therapeutics
ANIK
|
6.43 M | $ 9.59 | -0.21 % | $ 141 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
795 K | $ 36.9 | 6.04 % | $ 3.81 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
3.87 M | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | USA |
 |
CorMedix
CRMD
|
70.8 K | $ 12.07 | 3.77 % | $ 614 M | USA |
 |
Axon Enterprise
AXON
|
48.4 M | $ 571.12 | 0.56 % | $ 43.3 B | USA |
 |
Celldex Therapeutics
CLDX
|
3.18 M | $ 26.95 | -0.79 % | $ 1.74 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
5.38 M | $ 2.6 | - | $ 16.3 M | USA |